Dynamiker Biotechnology (Tianjin) Co., Ltd.

Dynamiker SARS-CoV-2 Ag Rapid Test

It is in-vitro qualitative detection of SARS-CoV-2 nucleocapsid antigen in direct nasopharyngeal/opharyngeal swabs, for professional use as an aid in COVID-19 diagnosis.

Contact Us

Specification

Catalogue

DNK-1425-1

Method

Colloidal gold

Specification

20 tests

Sample

Nasopharyngeal or oropharyngeal swab

Storage

2-30℃


Principle

Principle

Procedure

Interpretation

Clinical Performance

Clinical Performance
  • The DYNAMIKERSARS-CoV-2 Ag Rapid Test has passed the validation criteria as described by the Swiss Society of Microbiology. At Ct-values of 23, 26 and 29, the DYNAMIKERSARS-CoV-2 Ag Rapid Test showed a technical sensitivity of 95.4 %, 91.5% and 85% compared to a reference standard showing a technical sensitivity of 95.4%, 96.6% and 92.6%, respectively. The technical specificity was 100%.


Get Touch With Dynamiker Now!
Send Us a Message
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept